ISIN | LU0415391605 |
---|---|
No. de valeur | 3882711 |
Bloomberg Global ID | BBG000PM9WQ5 |
Nom de fond | Bellevue Medtech & Services B Cap |
Prestataire de fonds |
Bellevue Asset Management AG
Zürich, Suisse Téléphone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Prestataire de fonds | Bellevue Asset Management AG |
Représentant en Suisse |
Waystone Fund Services (Switzerland) SA Lausanne Téléphone: 0041213111781 |
Distributeur(s) |
Bank am Bellevue AG Küsnacht Téléphone: +41 44 267 67 67 |
Classe d'actifs | Fonds en actions |
EFC Catégorie | |
Catégorie de parts | Accumulation |
Pays d'origine | Luxembourg |
Conditions d'émission de parts | Frais de transaction en faveur du fonds (participation à la couverture des frais lors du placement de nouvelles ressources entrées) |
Conditions de rachat de parts | Pas de commission de rachat et/ou de taxes en faveur du fonds (le rachat a lieu à la valeur d'inventaire) |
Stratégie d'investissement *** | The sub-fund is an equity fund. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two-thirds of the net assets of the sub-fund in a portfolio of carefully chosen shares and other equity securities of companies in the medical technology industry or companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. Without restricting the scope of the term “medtech and services”, companies in the medtech and services sector consist of companies primarily engaged in the production, development, funding, marketing and sale of medical devices and the provision of technical medical services, such as hospitals and laboratories, or the facilitation of processes relevant to these facilities; as well as entities primarily engaged in investing in or financing such companies. |
Particularités |
Prix actuel * | 440.65 CHF | 31.10.2024 |
---|---|---|
Prix précédent * | 447.08 CHF | 30.10.2024 |
Max 52 semaines * | 462.63 CHF | 27.03.2024 |
Min 52 semaines * | 366.76 CHF | 10.11.2023 |
NAV * | 440.65 CHF | 31.10.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Prix minimal indicatif | ||
Actifs du fonds *** | 1'461'027'542 | |
Actifs de la classe *** | ||
Trading Information SIX |
YTD Performance | +12.19% |
29.12.2023 - 31.10.2024
29.12.2023 31.10.2024 |
---|---|---|
1 mois | -0.67% |
30.09.2024 - 31.10.2024
30.09.2024 31.10.2024 |
3 mois | +2.75% |
31.07.2024 - 31.10.2024
31.07.2024 31.10.2024 |
6 mois | 0.00% |
30.04.2024 - 31.10.2024
30.04.2024 31.10.2024 |
1 an | +20.42% |
31.10.2023 - 31.10.2024
31.10.2023 31.10.2024 |
2 ans | +1.80% |
31.10.2022 - 31.10.2024
31.10.2022 31.10.2024 |
3 ans | -10.68% |
02.11.2021 - 31.10.2024
02.11.2021 31.10.2024 |
5 ans | +19.44% |
31.10.2019 - 31.10.2024
31.10.2019 31.10.2024 |
Quota de participation de capital en % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Part de la fortune du fonds en % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quota d'immobilier en % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Boston Scientific Corp | 9.83% | |
---|---|---|
Intuitive Surgical Inc | 9.79% | |
Abbott Laboratories | 9.63% | |
Stryker Corp | 8.91% | |
Medtronic PLC | 4.88% | |
Becton Dickinson & Co | 4.66% | |
Essilorluxottica | 3.98% | |
Alcon Inc | 3.88% | |
Edwards Lifesciences Corp | 3.26% | |
GE HealthCare Technologies Inc Common Stock | 2.53% | |
Dernière mise à jour des données | 31.08.2024 |
TER | 2.23% |
---|---|
Date TER | 01.02.2021 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.60% |
Ongoing Charges *** | 2.16% |
SRRI ***
|
|
Date SRRI *** | 30.09.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |